WENDY PORR: Open Payments
NPI 1710987136 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 42 payments from 19 companies in 2025. Trend: 2023 $885 · 2024 $888 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $99 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Novo Nordisk Inc | 4 | $73 |
| Abbott Laboratories | 3 | $69 |
| PFIZER INC. | 4 | $68 |
| Amgen Inc. | 3 | $46 |
| Esperion Therapeutics, Inc. | 3 | $43 |
| Impulse Dynamics (USA) Inc. | 2 | $40 |
| AtriCure, Inc. | 1 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $31 |
Products named: LEQVIO, Wegovy, ELIQUIS, CAMZYOS, REPATHA, NEXLETOL, Optimizer, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.
Industry payments across NJ — which companies pay providers there.
